Background Based on the site of breakpoint in t (9; 22)(q34; q11), bcr-abl fusion in leukemia
patients is associated with different types of transcript proteins. In this study we have seen …

OBJECTIVE: This study aimed to verify the association between human leukocyte antigens
and the bcr-abl fusion protein resulting from t (9; 22)(q34; q11) in chronic leukemia myeloid …

Chronic myeloid leukemia (CML) is characterized by the chromosomal translocation t (9; 22)
resulting in the chimeric bcr-abl oncogene that encodes the P210 fusion protein, which …

Background: Different BCR-ABL fusion transcripts occur more or less frequently, in three
different types of leukemia Objectives: This study was done to determine the frequencies of …

CML is characterized by the chromosomal translocation t (9; 22)(q34; q11) resulting in the
chimeric bcr-abl oncogene that encodes P210 fusion proteins with novel amino acid …

We read with interest the article by Lucas et al. in this Journal focussing on the impact of the
BCR-ABL transcript type (e13a2 versus e14a2) in newly diagnosed patients with chronic …

This study was aimed to investigate the corelation between the HLA (human leukocyte
antigen) genes and susceptibility of leukeamia. 605 patients with leukeamia including 189 …

Background and objective: The characteristic chromosomal translocation t (9; 22)(q34; q11)
in chronic myeloid leukaemia (CML) mainly results in the two different BCR/ABL fusion …

Peptides corresponding to the fusion site in 210 kD BCR-ABL protein b3a2 (p210b3a2)
were previously shown to bind to several HLA class I and II alleles. We have found that b3a2 …

Purpose: The aim of this study was to search the BCR/ABL 1 fusion gene in 45 chronic
myeloid leukemia (CML) Syrian patients using nested reverse transcription polymerase …